Catapult Life Science is a Norwegian company, building up to become a Contract Development and Manufacturing Organization (CDMO). A center with infrastructure, equipment, and expertise to promote development of biotech and pharma products in Norway. We are based at Fornebu, nearby the Oslo based Norwegian life science environment. We recognize the importance of proximity to a manufacturer, that will enable the first steps for startup companies towards industrialization. Catapult is a member of The Life Science Cluster (TLSC) and Oslo Cancer Cluster (OOC).


Catapult aims to be a reliable and recognized Contract Development and Manufacturing Organization (CDMO) for Life Science and Pharma. Catapult will take part in placing Norway on the map, as a place where national and international players can find the infrastructure and expertise they need to develop their businesses.


Kristin Merete Schoultz


Kristin has a background as PhD in radiochemistry (1999) from the University of Oslo and University of Duke, North Carolina, USA. She has worked within the Nycomed-Amersham-GE Healhcare business in the period 1999 – 2010 with pharmacovigillance, clinical studies, technology transfer, QA within R&D and commercials. Kristin has been QA Director at Clavis Pharma and Department Director Biophamaceutical production, Norwegian Institute of Public Health and has competence and experience within contract manufacturing. She co-founded Catapult Life Science.  

Idunn Sundfør

Quality Assurance and Quality Control manager

Idunn holds a Master of Science degree in toxicology from the University in Oslo (UiO). She has 15 years of QA and QC experience from laboratory and pharma industries (GxP) including 8 years in the department of Biopharmaceutical Production, at the Norwegian Institute of Public Health. Idunn joined the Catapult team in 2017.

Gro Helene Osnes

Production and Project Manager

Gro Helene is a medical technologist and holds a Master of Science in biotechnology from NTNU. From 2006, she worked in the department of Biopharmaceutical Production at the Norwegian Institute of Public Health with contract manufacturing of pharmaceuticals and medical devices for clinical trials. She was responsible for aseptic fill & finish as a production leader, in addition to project management. In 2018, she started as a Production and Project manager in Catapult.

Goro Ligård

Microbiologist and QC-analyst

Goro is a Master of Science in Biotechnology with specialization in microbiology, from The Norwegian University of Life Sciences (UMB/NMBU). She has worked in the food industry as a quality coordinator, where she participated in internal audits and quality work. From 2012 – 2018, she worked according to GMP at the quality control unit at Biopharmaceutical Production at the Norwegian Institute of Public Health, and performed various microbiological analyses and quality work.

Jhansi Panga

Laboratory Engineer

Jhansi is master in Biochemistry from Andhra University in India 2009. She has worked as QA Assistant in Novartis Norway and as lab technician in Invicta, performing chemical analyses. She has also worked in the Department of Biopharmaceutical Production at the Norwegian Institute of Public Health, with archiving, environmental control and other GMP-related work.

Anders Stokvold

Laboratory Engineer

Anders is a Master of Technology in Industrial Chemistry, Polymer Chemistry and Catalysis from NTH/NTNU. He held a research position at Nycomed Imaging/Amersham/GE Healthcare from 1998-2014, with experience from instrument qualification and validation, and GMP. From 2015 he worked in the department of biopharmaceutical production at the Norwegian Institute of Public Health, and from 2017 to 2019 with ISO 17025 accredited analysis at NIVA. In 2019 Anders worked in Diatec Monoclonals.


Trond Johansen


Trond Johansen is the owner and operator of the medical device company Kiritec, which operates in Scandinavia, as well as the investment company Fonct Management. Trond is educated Cand. Merc. from the Aarhus School of Business, he has worked for 30 years in the medical industry and has gained a wide experience in the field of biotech – medical. He has invested in biotec for the last 10 years, especially in Norway. Trond lives in Denmark and has completed the Board of Governance training.

Naja Dannow

Board member

Naja mainly deals with real estate transactions, lease agreements and agreements concerning purchase, sale and development of real estate, but she also has extensive experience within company and corporate law and other transactions than within real estate. Naja assists in all elements of a transaction process, including advice on choice of transaction form, contract negotiations, due diligence, company formalities and implementation and settlement. In addition, Naja holds particular competence in corporate governance.

Kjeld-Håkon Nilsen

Board member

Kjeld-Håkon has an MBA and State Authorized Public Accountant from the Norwegian School of Economics (NHH). He has 20 years of experience as an accountant and thereby gained experience and knowledge about a wide number of industries. The last 10 years in the accountant business he was the owner and operator of Lani Revisjon AS. Today, Kjeld-Håkon is the CEO and partner in Jandersen Kapital AS, which is a private investment company primarily within life science and biotechnology industries.

Anders Stokvold

Board member

Anders is a Master of Technology in Industrial Chemistry, Polymer Chemistry and Catalysis. He has extensive experience with GMP production, documentation and analysis. From 2002 to 2014 Anders served as a local representative and leader in Tekna at GE. Anders has commercial interest in Norwegian biotech and has served as a fundraiser for Catapult Life Science.


Catapult Life Science


Five founders realize that Pilot Plant at GE Healthcare and Biopharmaceutical Production at the Norwegian Institute of National Health are closing down.


Catapult Life Science is founded in June. Pilot Plant GE Healthcare and others make equipment available. GMP Quality system is being developed.


Catapult Life Science opening ceremony of the Development Department in August.


Catapult Life Science builds QC laboratory. Signs partnering agreement with Diatec Monoclonals. Cleanrooms according to GMP/ISO 14644 is build.



Cleanrooms opens in February and in May the first manufacturing license for QC analyses is given by the Norwegian Health Authorities.


Catapult Life Science is restructured to become a CDMO. Business and strategy is pinpointed towards manufacturing, formulation, fill and finish approval by national and international regulatory agencies.